David L Marks

Title: David L Marks: Innovator in Sphingolipid Analog Research

Introduction

David L Marks is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of biochemistry, particularly in the development of non-natural sphingolipid analogs. His work has implications for various medical applications, especially in the treatment of diseases related to cellular processes.

Latest Patents

David L Marks holds a patent for "Non-natural sphingolipid analogs and uses thereof." This patent provides a composition that is useful for inhibiting caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells. The composition consists of non-natural analogs of sphingolipids and may have applications in treating diseases associated with these cellular processes. Additionally, the patent outlines methods for making and using the described composition.

Career Highlights

David L Marks is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance research in his field. His innovative work has positioned him as a key figure in the study of sphingolipids and their potential therapeutic uses.

Collaborations

Some of his notable coworkers include Richard E Pagano and Robert Bittman. Their collaborative efforts contribute to the ongoing research and development in the area of sphingolipid analogs.

Conclusion

David L Marks is a prominent inventor whose work on non-natural sphingolipid analogs has the potential to impact medical science significantly. His contributions to the field highlight the importance of innovation in addressing complex biological challenges.